Vitathreads LLC Reports Meeting Primary And Secondary Endpoints In Pre-Clinical Studies Demonstrating Effectiveness Of The Vitasuture Wound Management System (VWMS)

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WORCESTER, Mass.--(BUSINESS WIRE)--VitaThreads LLC today reported that the VitaSuture Wound Management Systems (VWMS) met a primary endpoint of incisional closure and secondary histological endpoints in pre-clinical in vivo animal studies. The study was conducted in a rat skin incision model system, evaluating the behavior of VWMS in 23 animals over the course of 57 days as compared to currently available sutures. VWMS demonstrated successful closure of evaluated wounds with no device-linked complications, with complete absorption of the suture material within 14 days, and minimal histological evidence of inflammation as compared to controls. Review by a board-certified histopathologist revealed less accompanying fibrosis and inflammation in suture absorption and wound healing than controls. Mechanical testing of VitaSuture demonstrated superior break strength to conventionally employed absorbable sutures by a factor of as much as 2x.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC